07 Jan 2001

Lederlon® 5 (Lederlon® 5/-20 Kristallsuspension) - Deutschland

Updated: 07 Jan 2001

Lederlon® 5 | -20

Intraartikulär: Arthritis, Arthrosen (akuter Schub), posttraumat. Gelenkreizungen. Sub- u. intraläsional: Keloide, Dermatosen. Infiltration: entzündl. u. rheumat. Prozesse im Bereich der Weichteile des Bewegungsapparates. Lederlon 20 zusätzlich; Intraglutäal: Alle Indikationen der systemischen Corticoidtherapie.

Lederlon® 5 Description, Presentation and Dosage

Lederlon® 5 Description

Lederlon® 5 Drug Class Description

Andere Stoffe

Lederlon® 5 Drug Description

1 Amp. (1 ml) enth.: Triamcinolonhexacetonid 5 mg/20 mg in mikrokristalliner Form.

Lederlon® 5 Generic Name

Lederlon® 5/-20 Kristallsuspension

Lederlon® 5 Presentation

Lederlon® 5 Presentation

Lederlon® 5/-20

Lederlon® 5 Manufacturer

Lederle

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Lederlon® 5 Dosage

Lederlon® 5 Adult Dosage

Benzylalkohol 9 mg, Polysorbat 80, Sorbitol, Wasser f. Inj.-zwecke.

Lederlon® 5 Precautions, Reactions and Contraindications

Lederlon® 5 Special Precautions

Lederlon® 5 Special Precautions

G 10, G 11. Injektion in Sehnen.

Related Drugs - Pain Management

Back to top